Journal of Neuro-Oncology

, Volume 98, Issue 3, pp 349–355 | Cite as

Central nervous system relapse continues to be a therapeutic challenge in extensive disease small-cell lung cancer patients with initial symptomatic brain metastases and good response to chemoradiotherapy

Clinical Study - Patient Study


A summary is presented of four case studies of extensive disease small-cell lung cancer patients with initial symptomatic brain metastases, who were initially successfully treated with concurrent chemoradiotherapy of the neurocranium followed by consolidation chemotherapy and thoracic chemoradiotherapy, but shortly after the initial treatment developed a sequence of central nervous system relapses despite second-line therapy. Symptoms of the effect on the central nervous system dominated the course of the cancer disease, whereas the primary tumor mass remained in complete remission in all four patients until the end of the follow-up period.


Chemoradiotherapy Brain metastases Small-cell lung cancer 


  1. 1.
    Seute T, Leffers P, ten Velde GPM et al (2004) Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer 100:801–806CrossRefPubMedGoogle Scholar
  2. 2.
    Hochstenbag MMH, Twijnstra A, Wilmink JT (2000) Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol 48:243–248CrossRefPubMedGoogle Scholar
  3. 3.
    Manapov F, Klautke G, Fietkau R (2008) Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. J Thorac Oncol 3(6):652–655CrossRefPubMedGoogle Scholar
  4. 4.
    Nugent JL, Bunn PA Jr, Matthews MJ et al (1979) CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 44:1885–1893CrossRefPubMedGoogle Scholar
  5. 5.
    Seute T, Leffers P, ten Velde GPM et al (2008) Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI). Cancer 112(8):1827–1834CrossRefPubMedGoogle Scholar
  6. 6.
    Postmus P, Smit E (1999) Chemotherapy for brain metastases of lung cancer: a review. Ann Oncol 10:753–759CrossRefPubMedGoogle Scholar
  7. 7.
    Mira JG, Chen TT, Livingston RB et al (1988) Outcome of prophylactic and therapeutic cranial irradiation in disseminated small cell lung carcinoma: a Southwest Oncology Group Study. Int J Radiat Oncol Biol Phys 14(5):861–865PubMedGoogle Scholar
  8. 8.
    Lee JS, Murphy WK, Glisson BS et al (1989) Primary chemotherapy of brain metastases in small cell lung cancer. J Clin Oncol 7:916–922PubMedGoogle Scholar
  9. 9.
    Hoskin PJ, Brada M (2001) Radiotherapy for brain metastases. Clin Oncol 13:91–94Google Scholar
  10. 10.
    Reboul F, Vincent P, Brewer Y, Faure CF, Taulelle M (1996) Chemoradiotherapy for brain metastases of lung origin. Results of a phase II study. ASCO Annual Meeting 1996; Abstract No: 1106Google Scholar
  11. 11.
    Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M (2000) Concurrent chemoradiotherapy with cisplatin-etoposide for patients with brain metastases from lung cancer: results at four years. Proc Am Soc Clin Oncol 19:2000 (abstr 1965)Google Scholar
  12. 12.
    Postmus PE, Haaxma-Reiche H, Smit EF et al (2000) Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy—a Phase III Study of the European Organization fort he Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 18(19):3400–3408PubMedGoogle Scholar
  13. 13.
    Kouvaris JR, Miliadou A, Kouloulias VE et al (2007) Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors. Onkologie 30(7):361–366CrossRefPubMedGoogle Scholar
  14. 14.
    Giannone L, Johnson DH, hande KR et al (1987) Favorable prognosis of brain metastases in small cell lung cancer. Ann Intern Med 106(3):386–389PubMedGoogle Scholar
  15. 15.
    Kochhar R, Frytak S, Shaw EG (1997) Survival of patients with extensive small-cell lung cancer who have only brain metastases at initial diagnosis. Am J Clin Oncol 20(2):125–127CrossRefPubMedGoogle Scholar
  16. 16.
    Videtic GM, Adelstein DJ, Mekhail TM et al (2007) Validation of the RTOG recursive partitioning analysis (RPA) classification for small cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys 1(67):240–243Google Scholar
  17. 17.
    Seute T, Leffers P, Wilmink JT et al (2006) Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy. J Clin Oncol 24(13):2079–2082CrossRefPubMedGoogle Scholar
  18. 18.
    Yue X, Zang OC (2004) Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases. Ai Zheng 23(12):1671–1676PubMedGoogle Scholar
  19. 19.
    Korfel A, Oehm C, von Pawel J et al (2002) Response to topotecan of symptomatic brain metastases of small cell lung cancer also after whole-brain irradiation: a multicentre phase II study. Eur J Cancer 38(13):1724–1729CrossRefPubMedGoogle Scholar
  20. 20.
    Postmus PE, Haaxma-Reiche H, Gregor A et al (1998) Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study. Radiother Oncol 46(1):29–32CrossRefPubMedGoogle Scholar
  21. 21.
    Hoskin PJ, Yarnold JR, Smith IE et al (1986) CNS relapse despite prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC). Int J Radiat Oncol Biol Phys 12(11):2025–2028PubMedGoogle Scholar
  22. 22.
    Auperin A, Arriagada R, Pignon JP et al (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission: prophylactic cranial irradiation overview collaborative group. N Engl J Med 341:476–484CrossRefPubMedGoogle Scholar
  23. 23.
    Abrey LE, Olson JD, Raizer JJ et al (2001) A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 53:259–265CrossRefPubMedGoogle Scholar
  24. 24.
    Omuro AM, Raizer JJ, Demopoulos A et al (2006) Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial. J Neurooncol 78:277–280CrossRefPubMedGoogle Scholar
  25. 25.
    Serizawa T, Ono J, Iichi T et al (2002) Gamma knife radiosurgery fro metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma. J Neurosurg 97:484–488PubMedGoogle Scholar
  26. 26.
    Sheehan J, Kondziolka D, Flickinger J et al (2005) Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg 102:247–254CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  1. 1.Department of Radiotherapy, Medical FacultyUniversity of RostockRostockGermany

Personalised recommendations